The Internet at large celebrated on Thursday morning (Dec. 17) when news broke that Martin Shkreli, hated pharmaceutical kingpin, was arrested by the FBI on suspicions of security fraud.
According to Reuters, the arrest follows a federal investigation into Shkreli’s time as manager of MSMB Capital Management and the CEO of pharmaceutical company Retrophin. Shkreli, who is the current CEO of Turing Pharmaceuticals, made headlines earlier this year after acquiring the life-saving drug Daraprim and jacking its price up from $13.50 to $750 per tablet.
The 32-year-old CEO also made news for being the one to purchase the Wu-Tang Clan’s one-copy-only new album, Once Upon a Time in Shaolin, for $2 million. Shkreli also popped up earlier this week to declare interest in bailing rapper Bobby Shmurda out of prison.
Shkreli is reportedly to be charged for illegally using Retrophin money to pay off debts from MSMB. Retrophin said that it had “fully cooperated” with the government’s investigation.